Longevity Health Inc.

NASDAQ: XAGE · Real-Time Price · USD
0.15
0.01 (4.09%)
At close: May 08, 2025, 3:58 PM
0.15
1.35%
After-hours: May 08, 2025, 07:55 PM EDT

Longevity Health Statistics

Share Statistics

Longevity Health has 30.12M shares outstanding. The number of shares has increased by 46.44% in one year.

Shares Outstanding 30.12M
Shares Change (YoY) 46.44%
Shares Change (QoQ) 44.08%
Owned by Institutions (%) n/a
Shares Floating n/a
Failed to Deliver (FTD) Shares 14,973
FTD / Avg. Volume 0.23%

Short Selling Information

The latest short interest is 4.6M, so 15.28% of the outstanding shares have been sold short.

Short Interest 4.6M
Short % of Shares Out 15.28%
Short % of Float 18.22%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.56 and the forward PE ratio is null. Longevity Health's PEG ratio is 0.02.

PE Ratio -0.56
Forward PE n/a
PS Ratio 115.96
Forward PS n/a
PB Ratio -1.24
P/FCF Ratio -1.33
PEG Ratio 0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Longevity Health.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.16, with a Debt / Equity ratio of -0.14.

Current Ratio 0.16
Quick Ratio 0.14
Debt / Equity -0.14
Debt / EBITDA -0.06
Debt / FCF -0.15
Interest Coverage -101.98

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $3,354.53
Profits Per Employee $-691,217.4
Employee Count 15
Asset Turnover 0.03
Inventory Turnover 0.06

Taxes

Income Tax -97.28K
Effective Tax Rate 0.91%

Stock Price Statistics

The stock price has increased by -93.12% in the last 52 weeks. The beta is 0.71, so Longevity Health's price volatility has been higher than the market average.

Beta 0.71
52-Week Price Change -93.12%
50-Day Moving Average 0.18
200-Day Moving Average 0.4
Relative Strength Index (RSI) 46.66
Average Volume (20 Days) 6,542,180

Income Statement

In the last 12 months, Longevity Health had revenue of 50.32K and earned -10.37M in profits. Earnings per share was -0.5.

Revenue 50.32K
Gross Profit 43.96K
Operating Income -5M
Net Income -10.37M
EBITDA -10.5M
EBIT -10.7M
Earnings Per Share (EPS) -0.5
Full Income Statement

Balance Sheet

The company has 157.14K in cash and 638.99K in debt, giving a net cash position of -481.85K.

Cash & Cash Equivalents 157.14K
Total Debt 638.99K
Net Cash -481.85K
Retained Earnings -68.87M
Total Assets 1.47M
Working Capital -4.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.39M and capital expenditures 0, giving a free cash flow of -4.39M.

Operating Cash Flow -4.39M
Capital Expenditures n/a
Free Cash Flow -4.39M
FCF Per Share -0.21
Full Cash Flow Statement

Margins

Gross margin is 87.37%, with operating and profit margins of -9933.82% and -20605.47%.

Gross Margin 87.37%
Operating Margin -9933.82%
Pretax Margin -21359.64%
Profit Margin -20605.47%
EBITDA Margin -20870.2%
EBIT Margin -9933.82%
FCF Margin -8722.42%

Dividends & Yields

XAGE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for XAGE.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -92.86
Piotroski F-Score 3